Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

InspireMD, Inc. Director's Dealing 2012

May 30, 2012

34187_dirs_2012-05-30_0249f770-792a-442b-bd8d-e9cbc551c0f9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR.OB)
CIK: 0001433607
Period of Report: 2012-05-25

Reporting Person: Shore Craig (CHIEF FINANCIAL OFFICER)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-05-25 Options to Purchase Common Stock (right to buy) $0.80 A 300000 Acquired 2022-05-25 Common stock (300000) Direct

Footnotes

F1: The option vests in three equal annual installments beginning on May 25, 2013.